Stay updated on Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.

Latest updates to the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page
- Check4 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2 in the footer, representing minor metadata updates rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedThe page history now shows Revision: v3.3.2 and removes Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the generic government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check54 days agoChange DetectedThe new screenshot shows minor formatting and layout tweaks to the Record History page (e.g., table spacing and header alignment) with no changes to study data, identifiers, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange Detected- Added a government-operating status notice and a new v3.2.0 version tag. - Removed the previous v3.1.0 tag.SummaryDifference12%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.